Literature DB >> 30799218

The reliability and clinical utility of ICD-11 schizoaffective disorder: A field trial.

Destiny L Peterson1, Christopher A Webb1, Jared W Keeley2, Wolfgang Gaebel3, Juergen Zielasek4, Tahilia J Rebello5, Rebeca Robles6, Chihiro Matsumoto7, Cary S Kogan8, Maya Kulygina9, Saeed Farooq10, Michael F Green11, Peter Falkai12, Alkomiet Hasan12, Silvana Galderisi13, Veronica Larach14, Valery Krasnov9, Geoffrey M Reed15.   

Abstract

A major goal for the revision of the International Classification of Diseases and Related Health Problems, Tenth Edition (ICD-10) is to increase the clinical utility of the diagnostic system. Schizoaffective disorder has a history of poor diagnostic reliability due to the similarities and overlap in symptoms that it shares with other disorders, especially primary psychotic and mood disorders. The present study was part of the case-controlled field trials for ICD-11 and examines how the proposed changes for schizoaffective disorder may improve differential diagnosis and diagnostic accuracy. Clinicians from around the globe (n = 873) were provided with either ICD-10 or ICD-11 diagnostic guidelines and asked to apply them to case vignettes comparing schizoaffective disorder to schizophrenia and mood disorders with psychotic symptoms. Participants were asked to respond to follow-up diagnostic questions to determine which components of the diagnostic guidelines affected diagnostic accuracy. Overall, clinicians showed small improvements in accurately diagnosing vignettes using ICD-11 over ICD-10. Results suggest the discrepancy in diagnosing schizoaffective disorder is related primarily to the presence of mood symptoms and discrepancies about whether those symptoms are more consistent with schizoaffective disorder or a mood disorder diagnosis. Continuing to identify ways to more accurately capture this symptom picture will be important in the future as well as systematic efforts to educate clinicians about differential diagnosis.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diagnosis; ICD-11; Mood disorders; Reliability; Schizoaffective disorder; Schizophrenia

Mesh:

Year:  2019        PMID: 30799218     DOI: 10.1016/j.schres.2019.02.011

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  4 in total

1.  Long-Term Real-World Effectiveness of Pharmacotherapies for Schizoaffective Disorder.

Authors:  Jonne Lintunen; Heidi Taipale; Antti Tanskanen; Ellenor Mittendorfer-Rutz; Jari Tiihonen; Markku Lähteenvuo
Journal:  Schizophr Bull       Date:  2021-07-08       Impact factor: 9.306

2.  The Italian ICD-11 field trial: clinical utility of diagnostic guidelines for schizophrenia and related disorders.

Authors:  Mario Luciano; Gaia Sampogna; Valeria Del Vecchio; Vincenzo Giallonardo; Carmela Palummo; Benedetta Pocai; Luca Steardo; Francesca Zinno; Tahilia Rebello; Geoffrey M Reed; Andrea Fiorillo
Journal:  Int J Ment Health Syst       Date:  2020-01-24

Review 3.  Complex PTSD: what is the clinical utility of the diagnosis?

Authors:  Åshild Nestgaard Rød; Casper Schmidt
Journal:  Eur J Psychotraumatol       Date:  2021-12-09

Review 4.  Changes from ICD-10 to ICD-11 and future directions in psychiatric classification
.

Authors:  Wolfgang Gaebel; Johannes Stricker; Ariane Kerst
Journal:  Dialogues Clin Neurosci       Date:  2020-03       Impact factor: 5.986

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.